Editorial

The Federal ‘Right To Try’ Act: An Answer to New Treatments During Terminal Illness?

Pamela Hallquist Viale, RN, MS, CNS, ANP


J Adv Pract Oncol 2017;8:334–336 | https://doi.org/10.6004/jadpro.2017.8.4.2 | © 2017 Harborside Press®


  

ABSTRACT

The newly proposed Federal “Right to Try” Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs. 



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here